{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:28:56Z","timestamp":1787045336444,"version":"build-2736575974"},"reference-count":27,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hymenoptera venom allergy (HVA) represents one of the most frequent causes of anaphylaxis in adults. Venom immunotherapy (VIT) remains the only causal intervention that effectively reduces the risk of systemic reactions following subsequent stings. Accelerated-induction protocols enable rapid attainment of the maintenance dose; however, data on their safety with depot preparations are still limited. To evaluate the safety of accelerated-induction VIT using a depot preparation in a real-world clinical setting. Materials and Methods: A retrospective, single-center study was conducted between 2022 and 2024; accelerated-induction VIT with a depot preparation was initiated in 54 consecutive patients at a tertiary referral center. All patients had a documented history of systemic allergic reactions after Hymenoptera stings. A three-day accelerated-induction protocol was applied. Safety outcomes and adverse events occurring during the induction phase were systematically recorded and analyzed. Results: All 54 patients successfully achieved the maintenance dose. Adverse reactions were observed only in five patients (9.3%) and were restricted to mild local reactions at the injection site, including erythema and localized swelling. No systemic reactions or cases of anaphylaxis were reported. None of the patients required permanent discontinuation of VIT. Conclusions: Accelerated-induction VIT using a depot preparation demonstrated a favorable safety profile. When performed in an experienced tertiary care setting, this approach allows for rapid attainment of the maintenance dose while maintaining excellent tolerability.<\/jats:p>","DOI":"10.3390\/medicina62081579","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:35:08Z","timestamp":1786984508000},"page":"1579","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Tolerability of Accelerated Venom Immunotherapy with Depot Extracts in Insect-Venom-Allergic Patients"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-8923","authenticated-orcid":false,"given":"Olga","family":"Branicka","sequence":"first","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Krupa-Lubas","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-2263","authenticated-orcid":false,"given":"Andrzej","family":"Bo\u017cek","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Disease, Dermatology and Allergology in Zabrze, Medical University of Silesia, 41-800 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-7344","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Balner","sequence":"additional","affiliation":[{"name":"Department of Allergology and Clinical Immunology, University Hospital Ostrava, University of Ostrava, 708-52 Ostrava, Czech Republic"},{"name":"Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, 703-00 Ostrava, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rados\u0142aw","family":"Gawlik","sequence":"additional","affiliation":[{"name":"Clinical Department of Internal Diseases, Allergology and Clinical Immunology in Katowice, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization Anaphylaxis Guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5114\/pdia.2017.70361","article-title":"Anaphylaxis in Poland: The epidemiology and direct costs","volume":"34","author":"Raciborski","year":"2017","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_3","unstructured":"Jahnz-R\u00f3\u017cyk, K., Kupczyk, M., and Gawlik, R. (2023). Alergologia w Praktyce Klinicznej. Cz\u0119\u015b\u0107 1, PZWL Wydawnictwo Lekarskie."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1398-9995.2005.00963.x","article-title":"Diagnosis of Hymenoptera venom allergy","volume":"60","author":"Rueff","year":"2005","journal-title":"Allergy"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fe\u00e1s, X., Vidal, C., and Remesar, S. (2022). What We Know about Sting-Related Deaths? Human Fatalities Caused by Hornet, Wasp and Bee Stings in Europe (1994\u20132016). Biology, 11.","DOI":"10.20944\/preprints202112.0483.v1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5414\/ALX02430E","article-title":"Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft f\u00fcr Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (\u00d6GAI)","volume":"7","author":"Bauer","year":"2023","journal-title":"Allergol. Sel."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5414\/ALX02420E","article-title":"Allergen immunotherapy of insect venom allergy: Almost 100 years old, but steadily updated","volume":"7","year":"2023","journal-title":"Allergol. Sel."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1080\/21645515.2017.1334745","article-title":"Allergen-specific immunotherapy of Hymenoptera venom allergy\u2014Also a matter of diagnosis","volume":"13","author":"Schiener","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0091-6749(92)90319-W","article-title":"Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety","volume":"89","author":"Helbling","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1034\/j.1398-9995.2000.00587.x","article-title":"Side-effects of insect venom immunotherapy: Results from an EAACI multicenter study","volume":"55","author":"Mosbech","year":"2000","journal-title":"Allergy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1517\/14656566.2011.616494","article-title":"Safety of hymenoptera venom immunotherapy: A systematic review","volume":"12","author":"Incorvaia","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e29450","DOI":"10.1016\/j.heliyon.2024.e29450","article-title":"The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial","volume":"10","author":"Zhi","year":"2024","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1081-1206(10)60003-8","article-title":"Accelerated immunotherapy schedules: Review of efficacy and safety","volume":"97","author":"Cox","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.18176\/jiaci.0879","article-title":"A Clustered Schedule for Venom Immunotherapy With a Depot Extract: Reaching the Target in 7 Days","volume":"33","author":"Vidal","year":"2023","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/all.16528","article-title":"A Safe and Efficient 7-Week Immunotherapy Protocol With Aluminum Hydroxide Adsorbed Bee Venom","volume":"80","author":"Schadelbauer","year":"2025","journal-title":"Allergy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/all.16128","article-title":"Efficacy and safety of a 7-week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom","volume":"79","author":"Kasternow","year":"2024","journal-title":"Allergy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3346\/jkms.2011.26.9.1159","article-title":"Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis","volume":"26","author":"Kim","year":"2011","journal-title":"J. Korean Med. Sci."},{"key":"ref_20","first-page":"40","article-title":"Phase II\/III clinical trial to assess the tolerability and immunological effect of a new updosing phase of Dermatophagoides mix-based immunotherapy","volume":"25","author":"Tabar","year":"2015","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101334","DOI":"10.1016\/j.waojou.2026.101334","article-title":"A prospective cohort study of ultra-rush subcutaneous immunotherapy in dust mite-induced allergic rhinitis","volume":"19","author":"Xiong","year":"2026","journal-title":"World Allergy Organ. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of hymenoptera venom allergy: Guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2011.01.025","article-title":"Stinging insect hypersensitivity: A practice parameter update 2011","volume":"127","author":"Golden","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2500\/aap.2024.45.240011","article-title":"Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum-adsorbed extracts","volume":"45","author":"Brunetto","year":"2024","journal-title":"Allergy Asthma Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s40629-025-00344-w","article-title":"Rush build-up of venom immunotherapy using a depot preparation: Learning from times of shortage","volume":"34","author":"Stoevesandt","year":"2025","journal-title":"Allergo J. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Vos","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1398-9995.1993.tb00690.x","article-title":"Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): Immunologic and clinical results of a prospective study over 3 years","volume":"48","author":"Wyss","year":"1993","journal-title":"Allergy"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1579\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:48:43Z","timestamp":1787042923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081579"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081579","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}